# C-Reactive Protein in Saliva as a Non-Invasive Marker of Metabolic Syndrome: A Systematic Review and Meta-Analysis

**Authors:** Mohammad Khalfan, Yash Brahmbhatt, Sarah Pagni, Ripple Garg, Ahmad A. Alkandari, Abrar Alkhesaili, Nouf Alsheredah, Nawal AlDhafeeri, Hawra Baroon, Woroud Al-Sulimmani, Shaikha Almatrouk, Fahad Alali, Hend Alqaderi

PMC · DOI: 10.3390/life16030403 · Life · 2026-03-02

## TL;DR

This study reviews evidence that salivary C-reactive protein levels may be a non-invasive indicator of metabolic syndrome, though more consistent research is needed.

## Contribution

The paper provides a systematic review and meta-analysis on salivary CRP as a potential non-invasive marker for metabolic syndrome.

## Key findings

- Salivary CRP levels were higher in individuals with metabolic syndrome compared to controls.
- There was substantial heterogeneity across studies, likely due to differences in population and methodology.
- No publication bias was detected in the included studies.

## Abstract

Metabolic syndrome (MetS) is a cluster of conditions that rely on low-grade systemic inflammation and increase the risk of cardiovascular disease, type 2 diabetes, and stroke. C-reactive protein (CRP) has attracted growing interest in saliva as a non-invasive alternative to serum CRP testing, though existing evidence remains inconsistent. This systematic review and meta-analysis evaluated the association between salivary CRP levels and MetS and examined the consistency of findings across populations and methodological approaches. PubMed, the Cochrane Library, and Web of Science were searched up to December 2024 following PRISMA 2020 guidelines. Nineteen studies involving 3265 participants with and without MetS were included. Random-effects meta-analysis demonstrated higher salivary CRP levels in individuals with MetS compared with controls (SMD = 1.02; 95% CI −0.23 to 1.81), with substantial heterogeneity (I2 = 98.91%), reflecting variation in population characteristics and saliva collection protocols. Funnel plot assessment did not indicate publication bias. Despite considerable heterogeneity, pooled estimates suggest that individuals with MetS have higher levels of salivary CRP. Longitudinal studies employing standardized methodologies are required before its clinical implementation can be considered.

## Linked entities

- **Diseases:** metabolic syndrome (MONDO:0000816), cardiovascular disease (MONDO:0004995), type 2 diabetes (MONDO:0005148), stroke (MONDO:0005098)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** cardiovascular disease (MESH:D002318), type 2 diabetes (MESH:D003924), stroke (MESH:D020521), inflammation (MESH:D007249), MetS (MESH:D024821)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028261/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028261/full.md

## References

112 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028261/full.md

---
Source: https://tomesphere.com/paper/PMC13028261